New Radiotheranostic Agent Offers Targeted Therapy in Metastatic Kidney Cancer

Scientists have developed a new radiotheranostic pair called 68Ga/177Lu-NYM096.

This agent can both detect tumors and deliver targeted radiotherapy in patients with metastatic clear cell renal cell carcinoma (ccRCC).